Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

New England Journal of Medicine

Volumn 344, Issue 24, 2001, Pages 1815-1822

  Laughlin, Mary J ^a,g   Barker, Juliet ^b   Bambach, Barbara ^c   Koc, Omer N ^a   Rizzieri, David A ^d   Wagner, John E ^b   Gerson, Stanton L ^a   Lazarus, Hillard M ^a   Cairo, Mitchell ^e   Stevens, Cladd E ^f   Rubinstein, Pablo ^f   Kurtzberg, Joanne ^d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f NEW YORK BLOOD CENTER   (United States)

^g UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HLA ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BLOOD STORAGE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HLA TYPING; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, CD34; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FETAL BLOOD; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPHILS; RECURRENCE; TRANSPLANTATION CONDITIONING;

EID: 0035859201     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200106143442402     Document Type: Article

References (37)

1. Treatment of adult acute leukemia
2. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
3. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings
4. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 Years' experience of the National Marrow Donor Program
5. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
6. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors
7. Allogeneic sibling umbilical-cord blood transplantation in children with malignant and non-malignant disease
8. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
9. Successful transplantation of HLA-matched and HLA-mismatched umbilical-cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease
10. Outcome of cordblood transplantation from related and unrelated donors
11. Placental and/or umbilical-cord blood: An alternative source of hematopoietic stem cells for transplantation
12. Outcomes among 562 recipients of placental-blood transplants from unrelated donors
13. Factors associated with outcome after cord blood transplantation in children with acute leukemia
14. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling
15. Cord blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia
16. Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia
17. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical-cord blood
18. Bone marrow transplantation - 1994: A report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry
19. Processing and cryopreservation of placental/umbilical-cord blood for unrelated bone marrow reconstitution
20. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: Results of a total body irradiation dose escalation trial
21. 1994 Consensus conference on acute GVHD grading
22. Pathophysiology and treatment of graft-versus-host disease
23. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies
24. Transplantation of marrow cells from unrelated donors for treatment of high-risk leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose
25. Importance of bone marrow cell dose in bone marrow transplantation
26. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors
27. Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome
28. Flow cytometric and functional characterization of AC133+ cells from human umbilical-cord blood
29. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: Implications for anatomical localization and developmental stage specific regulation of hematopoiesis
30. Candidate hematopoietic stem cells from fetal tissues, umbilical-cord blood vs. adult bone marrow and mobilized peripheral blood
31. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: Role in transendothelial/stromal migration and engraftment of NOD/SCID mice
32. A comparative analysis of the transplant potential of umbilical-cord blood versus mobilized peripheral blood stem cells
33. Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells
34. Treatment of leukemia by marrow transplantation from HLA incompatible donors: Effect of HLA-disparity on GVHD, relapse and survival
35. Reduced NFAT1 protein expression in human umbilical-cord blood T lymphocytes
36. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: Relevance to umbilical-cord blood transplantation
37. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation